Back to Stakeholders

Roswell Park Comprehensive Cancer Center in Buffalo, NY operates a Psychedelic Science Initiative (PSI) conducting research on psilocybin and ketamine for cancer patients; active trials include an open-label psilocybin microdosing study for chronic cancer pain and opioid reduction, a Phase 2 trial of the novel psychedelic RE104 for adjustment disorder in cancer patients, and a palliative esketamine clinic for co-morbid treatment-resistant depression.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Care Delivery Snapshot

Health Systems & Hospitals

Provider Model

Health System / Hospital Program

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

Global

Service Profile

Care Settings

Hospital Outpatient

Payer Models

Unknown

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Backfilled profile for existing L2 clinical care delivery stakeholder.

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

1